The fundamental purpose of this research was to evaluate whether TRPM2 suppression could be a therapeutic approach for treating DN, and to determine whether renal tubular epithelial cells are involved in the pathological process of DN. The gene discussed is TRPM2; the disease is liver dysplastic nodule.